nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA1B—vas deferens—urinary bladder cancer	0.323	0.827	CbGeAlD
Propericiazine—ADRA1B—renal system—urinary bladder cancer	0.0197	0.0504	CbGeAlD
Propericiazine—Pigmentation disorder—Thiotepa—urinary bladder cancer	0.0177	0.0291	CcSEcCtD
Propericiazine—Arrhythmia supraventricular—Gemcitabine—urinary bladder cancer	0.0128	0.0211	CcSEcCtD
Propericiazine—Pigmentation disorder—Etoposide—urinary bladder cancer	0.0127	0.0209	CcSEcCtD
Propericiazine—ADRA2A—prostate gland—urinary bladder cancer	0.0123	0.0316	CbGeAlD
Propericiazine—Parkinsonism—Fluorouracil—urinary bladder cancer	0.0108	0.0177	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—urinary bladder cancer	0.0105	0.0172	CcSEcCtD
Propericiazine—ADRA2A—seminal vesicle—urinary bladder cancer	0.0104	0.0267	CbGeAlD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—urinary bladder cancer	0.00971	0.0159	CcSEcCtD
Propericiazine—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00967	0.0159	CcSEcCtD
Propericiazine—Pneumonia—Valrubicin—urinary bladder cancer	0.00961	0.0158	CcSEcCtD
Propericiazine—Sudden death—Fluorouracil—urinary bladder cancer	0.00957	0.0157	CcSEcCtD
Propericiazine—ADRA2A—urethra—urinary bladder cancer	0.00825	0.0211	CbGeAlD
Propericiazine—Venous thromboembolism—Epirubicin—urinary bladder cancer	0.00811	0.0133	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—urinary bladder cancer	0.0075	0.0123	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—urinary bladder cancer	0.00714	0.0117	CcSEcCtD
Propericiazine—Amenorrhoea—Thiotepa—urinary bladder cancer	0.00674	0.011	CcSEcCtD
Propericiazine—ADRA2A—female reproductive system—urinary bladder cancer	0.00673	0.0172	CbGeAlD
Propericiazine—Pigmentation disorder—Doxorubicin—urinary bladder cancer	0.00661	0.0108	CcSEcCtD
Propericiazine—Drowsiness—Mitomycin—urinary bladder cancer	0.00658	0.0108	CcSEcCtD
Propericiazine—ADRA2A—vagina—urinary bladder cancer	0.00608	0.0156	CbGeAlD
Propericiazine—Infection—Carboplatin—urinary bladder cancer	0.00561	0.0092	CcSEcCtD
Propericiazine—Liver injury—Cisplatin—urinary bladder cancer	0.00551	0.00905	CcSEcCtD
Propericiazine—Sudden death—Methotrexate—urinary bladder cancer	0.00498	0.00816	CcSEcCtD
Propericiazine—Vision blurred—Mitomycin—urinary bladder cancer	0.00485	0.00795	CcSEcCtD
Propericiazine—Body temperature increased—Valrubicin—urinary bladder cancer	0.00482	0.0079	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—urinary bladder cancer	0.00472	0.00775	CcSEcCtD
Propericiazine—Body temperature increased—Carboplatin—urinary bladder cancer	0.00446	0.00732	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—urinary bladder cancer	0.00437	0.00717	CcSEcCtD
Propericiazine—Confusional state—Mitomycin—urinary bladder cancer	0.00423	0.00694	CcSEcCtD
Propericiazine—Oedema—Mitomycin—urinary bladder cancer	0.0042	0.00689	CcSEcCtD
Propericiazine—Deep vein thrombosis—Methotrexate—urinary bladder cancer	0.00419	0.00687	CcSEcCtD
Propericiazine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00417	0.00684	CcSEcCtD
Propericiazine—Photosensitivity—Fluorouracil—urinary bladder cancer	0.00405	0.00664	CcSEcCtD
Propericiazine—ADRA2A—lymph node—urinary bladder cancer	0.00393	0.0101	CbGeAlD
Propericiazine—Vomiting—Valrubicin—urinary bladder cancer	0.00387	0.00636	CcSEcCtD
Propericiazine—Rash—Valrubicin—urinary bladder cancer	0.00384	0.0063	CcSEcCtD
Propericiazine—Dermatitis—Valrubicin—urinary bladder cancer	0.00384	0.0063	CcSEcCtD
Propericiazine—Dyspnoea—Mitomycin—urinary bladder cancer	0.00374	0.00614	CcSEcCtD
Propericiazine—Somnolence—Mitomycin—urinary bladder cancer	0.00373	0.00612	CcSEcCtD
Propericiazine—Nasal congestion—Cisplatin—urinary bladder cancer	0.0037	0.00606	CcSEcCtD
Propericiazine—Nausea—Valrubicin—urinary bladder cancer	0.00362	0.00594	CcSEcCtD
Propericiazine—Weight increased—Thiotepa—urinary bladder cancer	0.00338	0.00554	CcSEcCtD
Propericiazine—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00335	0.00549	CcSEcCtD
Propericiazine—Pneumonia—Thiotepa—urinary bladder cancer	0.00333	0.00546	CcSEcCtD
Propericiazine—Body temperature increased—Mitomycin—urinary bladder cancer	0.00332	0.00544	CcSEcCtD
Propericiazine—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00329	0.00539	CcSEcCtD
Propericiazine—Jaundice—Thiotepa—urinary bladder cancer	0.00323	0.00529	CcSEcCtD
Propericiazine—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00309	0.00507	CcSEcCtD
Propericiazine—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00307	0.00503	CcSEcCtD
Propericiazine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00304	0.00499	CcSEcCtD
Propericiazine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00287	0.00471	CcSEcCtD
Propericiazine—Sweating increased—Cisplatin—urinary bladder cancer	0.00284	0.00465	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—urinary bladder cancer	0.00283	0.00465	CcSEcCtD
Propericiazine—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00282	0.00462	CcSEcCtD
Propericiazine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.0028	0.0046	CcSEcCtD
Propericiazine—Pneumonia—Gemcitabine—urinary bladder cancer	0.0028	0.00459	CcSEcCtD
Propericiazine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00276	0.00452	CcSEcCtD
Propericiazine—Pneumonia—Fluorouracil—urinary bladder cancer	0.00275	0.00452	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00271	0.00445	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—urinary bladder cancer	0.00271	0.00445	CcSEcCtD
Propericiazine—Vomiting—Mitomycin—urinary bladder cancer	0.00267	0.00438	CcSEcCtD
Propericiazine—Arrhythmia—Thiotepa—urinary bladder cancer	0.00265	0.00435	CcSEcCtD
Propericiazine—Rash—Mitomycin—urinary bladder cancer	0.00265	0.00434	CcSEcCtD
Propericiazine—Dermatitis—Mitomycin—urinary bladder cancer	0.00264	0.00434	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—urinary bladder cancer	0.00262	0.0043	CcSEcCtD
Propericiazine—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.0026	0.00426	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—urinary bladder cancer	0.0026	0.00426	CcSEcCtD
Propericiazine—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00256	0.00419	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—urinary bladder cancer	0.00255	0.00418	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—urinary bladder cancer	0.00254	0.00416	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—urinary bladder cancer	0.00251	0.00412	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00251	0.00412	CcSEcCtD
Propericiazine—Nausea—Mitomycin—urinary bladder cancer	0.00249	0.00409	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—urinary bladder cancer	0.00246	0.00403	CcSEcCtD
Propericiazine—Vision blurred—Thiotepa—urinary bladder cancer	0.00244	0.004	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—urinary bladder cancer	0.00239	0.00392	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—urinary bladder cancer	0.00238	0.00391	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—urinary bladder cancer	0.00238	0.00391	CcSEcCtD
Propericiazine—Agitation—Thiotepa—urinary bladder cancer	0.00238	0.0039	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.00235	0.00385	CcSEcCtD
Propericiazine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00232	0.00381	CcSEcCtD
Propericiazine—Jaundice—Etoposide—urinary bladder cancer	0.00232	0.0038	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—urinary bladder cancer	0.00228	0.00374	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00227	0.00373	CcSEcCtD
Propericiazine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00223	0.00366	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—urinary bladder cancer	0.00222	0.00364	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—urinary bladder cancer	0.0022	0.00362	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.0022	0.00362	CcSEcCtD
Propericiazine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.0022	0.0036	CcSEcCtD
Propericiazine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00216	0.00355	CcSEcCtD
Propericiazine—Confusional state—Thiotepa—urinary bladder cancer	0.00213	0.00349	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—urinary bladder cancer	0.0021	0.00345	CcSEcCtD
Propericiazine—Infection—Thiotepa—urinary bladder cancer	0.0021	0.00344	CcSEcCtD
Propericiazine—Arrhythmia—Cisplatin—urinary bladder cancer	0.00208	0.00341	CcSEcCtD
Propericiazine—Tachycardia—Thiotepa—urinary bladder cancer	0.00206	0.00338	CcSEcCtD
Propericiazine—Vision blurred—Fluorouracil—urinary bladder cancer	0.00202	0.00331	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—urinary bladder cancer	0.00198	0.00325	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—urinary bladder cancer	0.00197	0.00323	CcSEcCtD
Propericiazine—Vision blurred—Cisplatin—urinary bladder cancer	0.00191	0.00314	CcSEcCtD
Propericiazine—Tremor—Cisplatin—urinary bladder cancer	0.0019	0.00312	CcSEcCtD
Propericiazine—Somnolence—Thiotepa—urinary bladder cancer	0.00188	0.00308	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—urinary bladder cancer	0.00184	0.00302	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00182	0.00299	CcSEcCtD
Propericiazine—Constipation—Thiotepa—urinary bladder cancer	0.00181	0.00296	CcSEcCtD
Propericiazine—Oedema—Gemcitabine—urinary bladder cancer	0.00178	0.00291	CcSEcCtD
Propericiazine—Infection—Gemcitabine—urinary bladder cancer	0.00176	0.00289	CcSEcCtD
Propericiazine—Confusional state—Fluorouracil—urinary bladder cancer	0.00176	0.00289	CcSEcCtD
Propericiazine—Oedema—Fluorouracil—urinary bladder cancer	0.00175	0.00286	CcSEcCtD
Propericiazine—Infection—Fluorouracil—urinary bladder cancer	0.00173	0.00285	CcSEcCtD
Propericiazine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00172	0.00282	CcSEcCtD
Propericiazine—Tachycardia—Fluorouracil—urinary bladder cancer	0.0017	0.0028	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—urinary bladder cancer	0.0017	0.00279	CcSEcCtD
Propericiazine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00167	0.00274	CcSEcCtD
Propericiazine—Hypotension—Gemcitabine—urinary bladder cancer	0.00166	0.00272	CcSEcCtD
Propericiazine—Oedema—Cisplatin—urinary bladder cancer	0.00166	0.00272	CcSEcCtD
Propericiazine—Infection—Cisplatin—urinary bladder cancer	0.00164	0.0027	CcSEcCtD
Propericiazine—Hypotension—Fluorouracil—urinary bladder cancer	0.00163	0.00268	CcSEcCtD
Propericiazine—Tachycardia—Cisplatin—urinary bladder cancer	0.00162	0.00265	CcSEcCtD
Propericiazine—Insomnia—Gemcitabine—urinary bladder cancer	0.00161	0.00264	CcSEcCtD
Propericiazine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.0016	0.00263	CcSEcCtD
Propericiazine—Asthma—Methotrexate—urinary bladder cancer	0.0016	0.00262	CcSEcCtD
Propericiazine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00158	0.0026	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00158	0.00259	CcSEcCtD
Propericiazine—Insomnia—Fluorouracil—urinary bladder cancer	0.00158	0.00259	CcSEcCtD
Propericiazine—Somnolence—Gemcitabine—urinary bladder cancer	0.00158	0.00259	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—urinary bladder cancer	0.00157	0.00258	CcSEcCtD
Propericiazine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00156	0.00255	CcSEcCtD
Propericiazine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00156	0.00255	CcSEcCtD
Propericiazine—Somnolence—Fluorouracil—urinary bladder cancer	0.00155	0.00255	CcSEcCtD
Propericiazine—Hypotension—Cisplatin—urinary bladder cancer	0.00155	0.00254	CcSEcCtD
Propericiazine—Confusional state—Etoposide—urinary bladder cancer	0.00153	0.00251	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—urinary bladder cancer	0.00152	0.00249	CcSEcCtD
Propericiazine—Infection—Etoposide—urinary bladder cancer	0.00151	0.00247	CcSEcCtD
Propericiazine—Asthma—Epirubicin—urinary bladder cancer	0.00149	0.00245	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—urinary bladder cancer	0.00148	0.00243	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—urinary bladder cancer	0.00148	0.00243	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00148	0.00242	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00147	0.00241	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00147	0.00241	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00146	0.00239	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.00146	0.00239	CcSEcCtD
Propericiazine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00144	0.00237	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—urinary bladder cancer	0.00143	0.00235	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—urinary bladder cancer	0.00142	0.00234	CcSEcCtD
Propericiazine—Hypotension—Etoposide—urinary bladder cancer	0.00142	0.00232	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.0014	0.0023	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—urinary bladder cancer	0.00138	0.00227	CcSEcCtD
Propericiazine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00138	0.00226	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00137	0.00225	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00136	0.00224	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—urinary bladder cancer	0.00136	0.00223	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—urinary bladder cancer	0.00135	0.00222	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00135	0.00221	CcSEcCtD
Propericiazine—Somnolence—Etoposide—urinary bladder cancer	0.00135	0.00221	CcSEcCtD
Propericiazine—Vomiting—Thiotepa—urinary bladder cancer	0.00134	0.0022	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—urinary bladder cancer	0.00134	0.0022	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—urinary bladder cancer	0.00133	0.00219	CcSEcCtD
Propericiazine—Rash—Thiotepa—urinary bladder cancer	0.00133	0.00218	CcSEcCtD
Propericiazine—Dermatitis—Thiotepa—urinary bladder cancer	0.00133	0.00218	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00133	0.00218	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00131	0.00215	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—urinary bladder cancer	0.0013	0.00213	CcSEcCtD
Propericiazine—Constipation—Etoposide—urinary bladder cancer	0.0013	0.00213	CcSEcCtD
Propericiazine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00129	0.00211	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00126	0.00207	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—urinary bladder cancer	0.00126	0.00206	CcSEcCtD
Propericiazine—Nausea—Thiotepa—urinary bladder cancer	0.00125	0.00206	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00125	0.00205	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00124	0.00204	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—urinary bladder cancer	0.00124	0.00203	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00123	0.00202	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00122	0.002	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00122	0.00199	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—urinary bladder cancer	0.0012	0.00197	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—urinary bladder cancer	0.0012	0.00197	CcSEcCtD
Propericiazine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00119	0.00196	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00119	0.00195	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00115	0.00189	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00113	0.00186	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—urinary bladder cancer	0.00113	0.00185	CcSEcCtD
Propericiazine—Rash—Gemcitabine—urinary bladder cancer	0.00112	0.00184	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00112	0.00184	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—urinary bladder cancer	0.00112	0.00183	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00111	0.00182	CcSEcCtD
Propericiazine—Vomiting—Fluorouracil—urinary bladder cancer	0.00111	0.00182	CcSEcCtD
Propericiazine—Rash—Fluorouracil—urinary bladder cancer	0.0011	0.00181	CcSEcCtD
Propericiazine—Dermatitis—Fluorouracil—urinary bladder cancer	0.0011	0.0018	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00107	0.00175	CcSEcCtD
Propericiazine—Nausea—Gemcitabine—urinary bladder cancer	0.00105	0.00173	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—urinary bladder cancer	0.00105	0.00173	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—urinary bladder cancer	0.00105	0.00172	CcSEcCtD
Propericiazine—Rash—Cisplatin—urinary bladder cancer	0.00104	0.00171	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—urinary bladder cancer	0.00104	0.00171	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—urinary bladder cancer	0.00104	0.0017	CcSEcCtD
Propericiazine—Nausea—Fluorouracil—urinary bladder cancer	0.00104	0.0017	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00103	0.00169	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000989	0.00162	CcSEcCtD
Propericiazine—Nausea—Cisplatin—urinary bladder cancer	0.000983	0.00161	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—urinary bladder cancer	0.000982	0.00161	CcSEcCtD
Propericiazine—Vomiting—Etoposide—urinary bladder cancer	0.000964	0.00158	CcSEcCtD
Propericiazine—Agitation—Epirubicin—urinary bladder cancer	0.000957	0.00157	CcSEcCtD
Propericiazine—Rash—Etoposide—urinary bladder cancer	0.000956	0.00157	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—urinary bladder cancer	0.000955	0.00157	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—urinary bladder cancer	0.000916	0.0015	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000908	0.00149	CcSEcCtD
Propericiazine—Infection—Methotrexate—urinary bladder cancer	0.000903	0.00148	CcSEcCtD
Propericiazine—Nausea—Etoposide—urinary bladder cancer	0.000901	0.00148	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—urinary bladder cancer	0.000886	0.00145	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000878	0.00144	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—urinary bladder cancer	0.000867	0.00142	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—urinary bladder cancer	0.000857	0.00141	CcSEcCtD
Propericiazine—Oedema—Epirubicin—urinary bladder cancer	0.00085	0.00139	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—urinary bladder cancer	0.000849	0.00139	CcSEcCtD
Propericiazine—Infection—Epirubicin—urinary bladder cancer	0.000845	0.00139	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—urinary bladder cancer	0.00083	0.00136	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000822	0.00135	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—urinary bladder cancer	0.000822	0.00135	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—urinary bladder cancer	0.00081	0.00133	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—urinary bladder cancer	0.000808	0.00132	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000803	0.00132	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—urinary bladder cancer	0.000794	0.0013	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—urinary bladder cancer	0.000793	0.0013	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—urinary bladder cancer	0.000787	0.00129	CcSEcCtD
Propericiazine—Infection—Doxorubicin—urinary bladder cancer	0.000781	0.00128	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—urinary bladder cancer	0.000769	0.00126	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000768	0.00126	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00076	0.00125	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000758	0.00124	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—urinary bladder cancer	0.000756	0.00124	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—urinary bladder cancer	0.000735	0.00121	CcSEcCtD
Propericiazine—Constipation—Epirubicin—urinary bladder cancer	0.000727	0.00119	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000718	0.00118	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—urinary bladder cancer	0.000711	0.00117	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000701	0.00115	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—urinary bladder cancer	0.000699	0.00115	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—urinary bladder cancer	0.000673	0.0011	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000672	0.0011	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000669	0.0011	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000626	0.00103	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000622	0.00102	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000622	0.00102	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000582	0.000954	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00058	0.000951	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—urinary bladder cancer	0.000578	0.000947	CcSEcCtD
Propericiazine—Rash—Methotrexate—urinary bladder cancer	0.000573	0.00094	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—urinary bladder cancer	0.000572	0.000939	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—urinary bladder cancer	0.000541	0.000887	CcSEcCtD
Propericiazine—Nausea—Methotrexate—urinary bladder cancer	0.00054	0.000885	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000538	0.000883	CcSEcCtD
Propericiazine—Rash—Epirubicin—urinary bladder cancer	0.000536	0.000879	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—urinary bladder cancer	0.000536	0.000878	CcSEcCtD
Propericiazine—Nausea—Epirubicin—urinary bladder cancer	0.000505	0.000828	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—urinary bladder cancer	0.0005	0.00082	CcSEcCtD
Propericiazine—Rash—Doxorubicin—urinary bladder cancer	0.000496	0.000814	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000496	0.000813	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—urinary bladder cancer	0.000467	0.000766	CcSEcCtD
